|
Advertisement | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 280, Issue 17, 17213-17220, April 29, 2005
ATP Binding Regulates Oligomerization and Endosome Association of RME-1 Family Proteins*
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
RME-1 has three predicted domains: an N-terminal P-loop nucleotide-binding domain, a central domain predicted to form a coiled-coil, and a C-terminal eps15 homology (EH)1 domain (10). Yeast two-hybrid analysis suggested that EHD1 self-dimerizes or oligomerizes possibly through the activity of its coiled-coil domain (14, 15). EHD1 also forms hetero-dimers or oligomers with EHD3, another member of the mammalian RME-1 protein family (14).
Two dominant-negative mutations have been identified in RME-1 that interfere with endocytic recycling even in the presence of wild-type RME-1 (10, 11). One dominant interfering mutation (G81R in C. elegans, G65R in mouse) was found in the P-loop. This form of the protein appears diffuse in the cell and lacks obvious endosome association. A second dominant interfering mutation was found very near the EH domain (G459R in C. elegans, G429R in mouse). This form of the protein remains associated with endosomal membranes and alters the morphology of endosomal membranes within the cell.
The observation that a mutation in the P-loop of RME-1 inhibits endocytic recycling strongly suggests that nucleotide plays an important role in RME-1 function. Therefore, in the present study, we directly examined the nucleotide binding properties of both C. elegans RME-1 and mRme-1. First, we investigated whether RME-1 could bind GTP or ATP in vitro and whether nucleotide hydrolysis occurred. Having determined that RME-1 binds and hydrolyzes ATP but not GTP, we further investigated the role of ATP in the oligomerization of RME-1 and, in turn, its role in the localization of RME-1 in the cell. Our results suggest that the oligomerization of RME-1 is required for its association with endosomes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Yeast Two-hybrid AnalysisRME-1 was expressed in yeast cells both as a fusion with the GAL4 DNA-binding domain and as a fusion with the Gal4 transcriptional activation domain using the Proquest system (Invitrogen) as described previously (16, 17). If these two forms of RME-1 bind to each other, they reconstitute an active Gal4 transcription factor and allow expression of integrated reporter genes responsive to Gal4. The full rme-1 coding region from yk271a1 (aa 1576), the N-terminal non-EH-containing region (aa 1472), a short N-terminal P-loop-containing sequence (aa 1218), a coiled-coil and EH domain-containing sequence (aa 97576), or a C-terminal EH-domain containing region (aa 432576) was PCR-amplified from cDNA yk271a1 and cloned into the NcoI and SpeI sites of Gal4-DNA-binding domain vector pDBleu (Invitrogen). Mutations equivalent to b1046 (G81R) and ar481 (G459R) were introduced into the full-length construct by site-directed mutagenesis using the QuikChange kit (Stratagene). All PCR products were fully sequenced. Each of these rme-1 coding regions was then subcloned into Gal4-activation domain vector PC86. Pairwise combinations of pDBleu(bait) and PC86(prey) plasmids were then assayed for the ability to activate HIS3, LacZ, and URA3 reporter genes in yeast strain MaV203 according to the Proquest system manufacturer's instructions (Invitrogen).
GST-Protein PreparationE. coli BL21/DE3 cells were transformed with pGEX-2T1 encoding RME-1 constructs. Cells were grown for 45 h at 37 °C from a culture that was inoculated at a ratio of 1:10 from a stock culture that was grown overnight. Upon reaching an OD of 1.0 (600 nm), the cells were induced with 0.1 mM isopropyl-1-thio-
-D-galactopyranoside for 3 h. The cells were then collected by centrifugation, resuspended in phosphate-buffered saline, pH 7.4, containing protease inhibitor mixture (Roche Applied Science) and 1 mM phenylmethylsulfonyl fluoride, and then lysed by a probe sonicator. After adding Triton X-100 at a final concentration of 0.05%, the mixture was incubated for 30 min at room temperature. The supernatant was collected by centrifugation and then loaded onto a column containing 1 ml of a 50% slurry of glutathione-agarose beads (Amersham Biosciences). GST fusion proteins were eluted from the beads by incubation with the 1 ml of glutathione elution buffer (10 mM reduced glutathione in 50 mM Tris-HCl, pH 8.0). The eluate collected from three elutions of the column was dialyzed overnight against Buffer A (100 mM KCl, 20 mM imidazole, 2 mM magnesium acetate, 1 mM dithiothreitol, pH 7.0).
Nucleotide Hydrolysis ActivityThe ATPase and GTPase activities of various constructs of RME-1 were determined from the release of 32P from [
32P]ATP and [
32P]GTP (PerkinElmer Life Sciences), respectively. Purified proteins were incubated with radioactive nucleotide in Buffer A at 25 °C. At various times, aliquots were withdrawn, and the 32P extracted from the solution was determined by counting in a Beckman LS3801 liquid scintillation counter (18, 19).
Equilibrium Dialysis StudiesEquilibrium dialysis was performed in dialysis chambers (Technilab, Model E-l) containing 0.8 ml of solution on each side of the dialysis membrane. The solution consisted of 10 µM [14C]ADP (200 mCi/mmol, Amersham Biosciences) and 30 units/ml creatine kinase/15 mM creatine phosphate (Sigma) or 10 µM [14C]ADP and 50 units/ml hexokinase/5 mM glucose (Sigma), whereas purified protein (10 µM) was added to only one side of the membrane at the beginning of the experiment. Then the dialysis chambers were gently rocked for 36 h at 4 °C. After dialysis, the nucleotide content of the solution on each side of the membrane was determined. Equilibrium dialysis was also performed using 10 µM [3H]GTP (1 mCi/ml, Amersham Biosciences), 3 mM phosphoenol pyruvate, and 1 unit/ml pyruvate kinase (Sigma) or 10 µM [35S]GTP
S (1 mCi/mmol, Amersham Biosciences).
Tissue Culture and Western BlottingHeLa cells were maintained in Dulbecco's modified Eagle's medium (BioSource International) supplemented with 10% fetal bovine serum, 2 mM glutamine, penicillin (100 unit/ml), and streptomycin (100 unit/ml) in a humidified incubator with 5% CO2 at 37 °C. Cells were transfected with the plasmid DNA using FuGENE 6 (Roche Diagnostics). Cells were depleted of ATP by treatment with NaN3 and deoxyglucose as described in Wu et al. (20). Western blot of the GFP-RME-1 constructs expressed in HeLa cells was performed by running the cytosol on SDS-PAGE gels (Invitrogen) and then immunoblotting using anti-GFP antibodies (Abcam, Cambridge, MA). The GFP band, detected by using chemiluminescent substrate (Pierce, catalog number 34080), was imaged using the densitometer (ChemiImager, Alpha Innotech Corp.).
Confocal MicroscopyCells grown on two-chamber 25-mm2 coverslips (Labtek) were imaged on a Zeiss LSM 510 confocal microscope. GFP-mRme-1 was imaged and photobleached using 488-nm laser light with a x40, 1.4 NA objective. A defined region was photobleached at high laser power, resulting in 5080% reduction in the fluorescence intensity. Scanning at low laser power monitored the fluorescence recovery after photobleaching. When data sets were compared, identical conditions were used in photobleaching the cells including the number of bleaches, the area of the photobleach region, and the time course of imaging at low laser power. Measuring diffusive GFP constructs on a fast time scale, we used the method as described in Zeng et al. (21).
Data AnalysisFor each experimental condition, a minimum of eight data sets was averaged to get the mean and standard deviation for each time point. Setting the maximum fluorescence to 100% and the minimum fluorescence to 0% normalized the fluorescence intensity data in each experiment. The very low laser intensity used in scanning the cell after the initial photobleach did not cause significant bleaching during our experiments, and therefore, no correction was necessary for this effect. Although the fluorescence of the total GFP pool in the cell was unaffected by scanning, the total recovery in most experiments was only about 80% of the initial fluorescence because about 20% of the total GFP pool in the cell was bleached by the initial bleach.
| RESULTS |
|---|
|
|
|---|
|
|
To definitively establish the preference of RME-1 for ATP over GTP, we performed equilibrium dialysis studies on Ce-RME-1 using labeled ATP and GTP. Due to the relatively large volume of soluble recombinant RME-1 required for this assay, the highest protein concentration we were able to use was 10 µM. As shown in Table I, at 10 µM concentration of nucleotide and protein, we obtained measurable binding of ATP. Assuming one nucleotide-binding site per molecule, the Kd for ATP was calculated to be about 30 µM for both Ce-RME-1 and Ce-RME-1(G459R), consistent with the Km value obtained from the double reciprocal plots of ATPase activity for these proteins. We could not detect any binding of GTP or GTP
S to Ce-RME-1 under identical conditions. We were unable to detect binding of ATP or GTP to mRme-1 in this assay, as expected given the relatively weak Km for ATP determined by nucleotide hydrolysis analysis.
|
We first confirmed that wild-type Ce-RME-1 molecules interact using the yeast two-hybrid system and found a strong and specific response, indicating that RME-1 monomers self-associate (Table II, supplemental Fig. S1). We then investigated the structural requirements for the RME-1:RME-1 interaction (Table II, supplemental Fig. S1) and found that whereas the EH domain was not required for interaction in the two-hybrid assay, both the coiled-coil domain and the P-loop domain were required. Of particular interest was our finding that Ce-RME-1(G81R), the dominant-negative P-loop mutant, failed to interact with itself or wild-type RME-1 in this assay. Similarly, Ce-RME-1(
P-loop), in which the P-loop was deleted, prevented RME-1 from interacting with itself or wild-type Ce-RME-1. In contrast, the dominant-negative G459R mutation near the EH domain did not interfere with the ability of Ce-RME-1 to interact with itself or wild-type Ce-RME-1. Therefore, our results with the yeast two-hybrid system indicate that an active ATP-binding domain is required for RME-1 to oligomerize. These results also indicate that the two dominant-negative forms of RME-1, G81R and G459R, likely interfere with recycling by different mechanisms (see "Discussion").
|
To test this proposition further, we expressed several new GFP-mRme-1 fusion proteins in cultured cells and analyzed their subcellular distribution. The first mutation was a deletion of the mRme-1 P-loop domain, GFP-mRme-1(
P-loop). This variant should not be able to bind nucleotide, as demonstrated in our in vitro assays (see above). The second mutation was a deletion of the major coiled-coil region of Rme-1(
coiled-coil), which should prevent mRme-1 from oligomerizing, as we found for a similar mutant RME-1 protein assayed for oligomerization in the yeast two-hybrid system. The third mutation was a deletion of the EH domain (
EH) of mRme-1, which should eliminate binding to partner proteins through this domain. Finally, we also expressed and analyzed the membrane association of existing GFP-mRme-1 fusion proteins G65R and G429R. All of these GFP-mRME-1 constructs, when expressed in HeLa cells, showed no significant degradation, as shown by the Western blot of these proteins (Fig. 1B).
Consistent with the data of Lin et al. (11), our results showed that wild-type GFP-mRme-1 and GFP-mRme-1(G429R) are bound to membranous structures, whereas GFP-mRme-1(G65R) is cytosolic. The distribution of mRme-1(
EH) was similar to that of wild-type and mRme-1(G429R) (Fig. 3, AC). Interestingly, the other two mutants, GFP-mRme-1(
P-loop) and GFP-mRme-1(
coiled-coil), gave a cytosolic appearance similar to the P-loop point mutant, G65R (Fig. 3, E and F). These results indicated that the association of mRme-1 with membranes is dependent on both nucleotide binding and homo-oligomerization.
|
EH mRme-1s recovered after photobleaching with a half-life of about 1 min. On the other hand, the GFP-mRme-1 fusions that appeared cytosolic, G65R,
P-loop, and
coiled-coil, showed a very rapid fluorescence recovery after photobleaching with a recovery half-life of about 1 s, only about twice that of GFP alone (Fig. 4B). This very rapid recovery was consistent with a free cytosolic localization of these proteins. These results suggested that when oligomerization of mRme-1 is prevented, either by deletion of the coiled-coil domain or by interference with the interaction of ATP with the P-loop domain, mRme-1 is unable to bind membranes and remains free in the cytosol.
|
coiledcoil,
P-loop, and G65R point mutants, measured in the presence of nucleotide (Fig. 4B).
|
| DISCUSSION |
|---|
|
|
|---|
RME-1/mRme-1/EHD1 has been shown to interact with several other proteins that are likely to function with RME-1 during membrane transport processes. EHD1/mRme-1 has been shown to form dimers or hetero-oligomers with the highly related protein EHD3 (14). In addition, EHD1/mRme-1 interacts through its EH domain with an actin-associated protein EHBP1 that, like EHD1/mRme-1 itself, is required for insulin-stimulated translocation of the GLUT4 to the plasma membrane (13). Finally, EHD1/mRme-1 has been shown to interact through its EH domain with Rabenosyn-5, a Rab4/Rab5 effector that plays an important role in transport from early endosomes to recycling endosomes (23).
In the present study, we showed that both Ce-RME-1 and mRme-1 bind and hydrolyze ATP. Although the Km for ATP (3080 µM) was rather weak, we could not detect any GTP binding, and therefore, we are confident that RME-1 is an ATP-rather than a GTP-binding protein, especially since the ATP concentration in living cells is significantly higher than the GTP concentration (24). Only with a co-factor that would have to change the relative affinity of both GTP and ATP can mRME-1 be a GTPase in the cell. Although the ATP hydrolysis rate was very slow, it is possible that one or more of the large number of proteins with which RME-1 interacts activates the RME-1 ATPase activity at an appropriate time and place. Alternatively, ATP hydrolysis could be related to the in vivo oligomerization of RME-1. Our data strongly suggested that interaction with ATP is required for RME-1 to oligomerize and that this oligomerization, in turn, is required for the RME-1 to bind to membranes in the cell. Mutation or deletion of the P-loop region caused most of the GFP-mRme-1 to dissociate from membranous structures, as did mutation of the coiled-coil domain. Furthermore, the dissociated protein was clearly cytosolic, as shown by the rate of recovery after photobleaching, being only twice that of GFP alone. In contrast, GFP-mRme-1 bound to membranes showed a much slower mobility. Depletion of ATP from the cell also caused GFP-mRme-1 to dissociate from membranes, and in the case of wild-type mRme-1, the rate of recovery after photobleaching indicated high mobility indicative of free diffusion in the cytosol. Mutant forms of the mRme-1 protein displayed lower mobility as determined by their rates of recovery, perhaps because mutant forms tend to aggregate after poor folding if they are not chaperoned by ATP-binding chaperones such as Hsp70.
Interestingly, the dominant-negative form of mRme-1, G429R, and a mutant form reported by some groups to be dominant-negative,
EH, not only still bound to membranes, but the photobleaching results showed that they exchange with cytosolic mRme-1 at the same rate as wild-type mRme-1. Therefore, these mutant forms of RME-1 probably still oligomerize (as demonstrated in our yeast two-hybrid analysis) and bind to membranes. These mutant forms lack a functional EH domain and so are probably not able to interact with EH-binding proteins in a way that allows them to complete a normal duty cycle on the membrane. When these types of dominant-negative mutant RME-1 proteins oligomerize with wild-type RME-1, the hetero-oligomers may be non-functional and sequester endogenous wild-type RME-1 in non-productive complexes, an effect that can be overcome by co-overexpression of wild-type RME-1 (10, 11). Dominant-negative activity of P-loop mutants such as G81R/G65R is likely to occur by a very different mechanism since such mutants cannot bind to endogenous wild-type RME-1 proteins (this work). This type of mutant RME-1 likely titrates out co-factors into non-functional complexes in the cytoplasm.
Our findings indicated that RME-1 requires ATP to oligomerize and that oligomerization is required for RME-1 to bind to membranes. Combined with observations that RME-1 may be involved in the formation of tubules that exit from recycling endosomes, our results raised the possibility that RME-1 acts in a manner similar to dynamin during clathrin-mediated endocytosis (4). In this model, oligomerization of RME-1 would be accompanied by ATP hydrolysis and would cause fission of tubules emanating from the recycling endosome. Dominant-negative RME-1 bearing a G429R mutation near the EH domain would interfere with the normal action of the oligomerized RME-1 by co-polymerizing with it and preventing its normal interaction with other proteins through its EH domain. Testing this model will require further studies of the ability of RME-1 to oligomerize as well as the relation of this oligomerization to ATP hydrolysis. Further studies to identify other protein partners of RME-1 and their effect on its ATP hydrolysis will also be necessary. Finally, it may be of interest to determine whether oligomerized RME-1, either alone or perhaps when bound to partner proteins, is able to interact with lipid vesicles in the same manner as dynamin, epsin, and amphyphisin.
| FOOTNOTES |
|---|
The on-line version of this article (available at http://www.jbc.org) contains a supplemental figure showing the requirements for Ce-RME-1 oligomerization. ![]()
Both authors contributed equally to this work. ![]()
|| A recipient of support from the Chicago Community Trust Searle Scholars Program. ![]()
** To whom correspondence should be addressed: Laboratory of Cell Biology, NHLBI, National Institutes of Health, 50 South Dr., Rm. 2537 MSC 8017, Bethesda, MD 20892-8017. Tel.: 301-496-1228; E-mail: greenel{at}helix.nih.gov.
1 The abbreviations used are: EH, eps15 homology; EHD, EH domain; GST, glutathione S-transferase; GFP, green fluorescent protein; EGFP, enhanced GFP; GTP
S, guanosine 5'-3-O-(thio)triphosphate; aa, amino acids; FRAP, fluorescence recovery after photobleaching; mRME-1, mammalian RME-1. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Y. Olswang-Kutz, Y. Gertel, S. Benjamin, O. Sela, O. Pekar, E. Arama, H. Steller, M. Horowitz, and D. Segal Drosophila Past1 is involved in endocytosis and is required for germline development and survival of the adult fly J. Cell Sci., February 15, 2009; 122(4): 471 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Doherty, A. R. Demonbreun, G. Q. Wallace, A. Cave, A. D. Posey, K. Heretis, P. Pytel, and E. M. McNally The Endocytic Recycling Protein EHD2 Interacts with Myoferlin to Regulate Myoblast Fusion J. Biol. Chem., July 18, 2008; 283(29): 20252 - 20260. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Krautz-Peterson, S. Chapman-Bonofiglio, K. Boisvert, H. Feng, I. M. Herman, S. Tzipori, and A. S. Sheoran Intracellular Neutralization of Shiga Toxin 2 by an A Subunit-Specific Human Monoclonal Antibody Infect. Immun., May 1, 2008; 76(5): 1931 - 1939. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Cuthbert, K. K. Davis, and J. E. Casanova Substrate specificities and activities of AZAP family Arf GAPs in vivo Am J Physiol Cell Physiol, January 1, 2008; 294(1): C263 - C270. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jovic, N. Naslavsky, D. Rapaport, M. Horowitz, and S. Caplan EHD1 regulates beta1 integrin endosomal transport: effects on focal adhesions, cell spreading and migration J. Cell Sci., March 1, 2007; 120(5): 802 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Larsen, S. Tuck, N. J. Faergeman, and J. Knudsen MAA-1, a Novel Acyl-CoA-binding Protein Involved in Endosomal Vesicle Transport in Caenorhabditis elegans Mol. Biol. Cell, October 1, 2006; 17(10): 4318 - 4329. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naslavsky, J. Rahajeng, M. Sharma, M. Jovic, and S. Caplan Interactions between EHD Proteins and Rab11-FIP2: A Role for EHD3 in Early Endosomal Transport Mol. Biol. Cell, January 1, 2006; 17(1): 163 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Naslavsky and S. Caplan C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? J. Cell Sci., September 15, 2005; 118(18): 4093 - 4101. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Braun, R. Pinyol, R. Dahlhaus, D. Koch, P. Fonarev, B. D. Grant, M. M. Kessels, and B. Qualmann EHD Proteins Associate with Syndapin I and II and Such Interactions Play a Crucial Role in Endosomal Recycling Mol. Biol. Cell, August 1, 2005; 16(8): 3642 - 3658. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |